ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Drugs Outcomes Research and Policies
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1606327
Effectiveness of Clopidogrel vs Ticagrelor based on the ABCD-GENE Score in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention
Provisionally accepted
- Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China;, Shenyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Effectiveness of Clopidogrel vs Ticagrelor based on the ABCD-GENE Score in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention
Keywords: CYP2C19 polymorphism, ABCD-GENE score, clopidogrel, ticagrelor, Percutaneous Coronary Intervention
Received: 05 Apr 2025; Accepted: 26 May 2025.
Copyright: © 2025 Xu, Na, Qiu, Qi, Yang, Li, Xu, Wang, Li and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yaling Han, Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China;, Shenyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.